Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials.
Beck EJ, Sherry AD, Florez MA, Kouzy R, Abi Jaoude J, Lin TA, Miller AM, Passy AH, Kupferman GS, Patel RR, Chino F, Higbie VS, Parseghian CM, Overman MJ, Minsky BD, Thomas CR Jr, Tang C, Msaouel P, Ludmir EB.
Beck EJ, et al. Among authors: passy ah.
Cancer Res Commun. 2024 Aug 1;4(8):2183-2188. doi: 10.1158/2767-9764.CRC-24-0265.
Cancer Res Commun. 2024.
PMID: 39099199
Free PMC article.